Peloton Wealth Strategists Abb Vie Inc. Transaction History

Peloton Wealth Strategists

$246 Million
Q3 2024

A detailed history of Peloton Wealth Strategists transactions in Abb Vie Inc. stock. As of the latest transaction made, Peloton Wealth Strategists holds 22,415 shares of ABBV stock, worth $3.94 Million. This represents 1.8% of its overall portfolio holdings.

Number of Shares

22,415

Previous 24,700 9.25%

Holding current value

$3.94 Million

Previous $4.24 Million 4.49%

% of portfolio

1.8%

Previous 1.77%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$163.84 - $199.33 $374,374 - $455,469	-2,285 Reduced 9.25%	22,415 $4.43 Million
Q2 2024 Aug 15, 2024	SELL	$154.79 - $180.76 $20,896 - $24,402	-135 Reduced 0.54%	24,700 $4.24 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $27,169 - $30,957	-170 Reduced 0.68%	24,835 $4.52 Million
Q4 2023 Feb 15, 2024	SELL	$137.6 - $154.97 $287,584 - $323,887	-2,090 Reduced 7.71%	25,005 $3.88 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $1.92 Million - $2.22 Million	-14,380 Reduced 34.67%	27,095 $4.04 Million
Q2 2023 Aug 10, 2023	SELL	$132.51 - $164.9 $284,896 - $354,535	-2,150 Reduced 4.93%	41,475 $5.59 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $11,568 - $13,323	-80 Reduced 0.18%	43,625 $6.95 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $221,296 - $265,392	-1,600 Reduced 3.53%	43,705 $7.06 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $8,723 - $10,005	-65 Reduced 0.14%	45,305 $6.08 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $379,693 - $482,714	-2,759 Reduced 5.73%	45,370 $6.95 Million
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $50,152 - $62,225	-380 Reduced 0.78%	48,129 $7.8 Million
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $62,309 - $78,839	-580 Reduced 1.18%	48,509 $6.57 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $208,544 - $236,728	-1,960 Reduced 3.84%	49,089 $5.3 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $336,672 - $375,072	3,200 Added 6.69%	51,049 $5.75 Million
Q1 2021 Jun 23, 2021	BUY	$102.3 - $112.62 $120,304 - $132,441	1,176 Added 2.52%	47,849 $5.18 Million
Q4 2020 Feb 17, 2021	BUY	$80.49 - $108.67 $56,343 - $76,069	700 Added 1.52%	46,673 $5 Million
Q3 2020 Nov 17, 2020	BUY	$85.91 - $100.83 $129,724 - $152,253	1,510 Added 3.4%	45,973 $4.03 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $1.36 Million - $1.81 Million	18,483 Added 71.14%	44,463 $4.37 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $597,786 - $906,317	9,268 Added 55.46%	25,980 $1.98 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $82,949 - $103,787	1,150 Added 7.39%	16,712 $1.48 Million
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $980,094 - $1.18 Million	15,562 New	15,562 $1.18 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peloton Wealth Strategists, based on Form 13F filings with the SEC.

News

Stay updated on Peloton Wealth Strategists with notifications on news.

Account

Peloton Wealth Strategists Abb Vie Inc. Transaction History